Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1301 - 1325 of 1455 in total
DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.
Investigational
Hki 357 is under investigation in clinical trial NCT00550381 (Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects).
Investigational
Experimental
Experimental
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
Investigational
OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical.
Investigational
Mosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.
Investigational
AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Investigational
Cipargamin has been used in trials studying the treatment of Malaria, Cure Rate, and Plasmodium Falciparum Malaria.
Investigational
MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.
Investigational
RO5028442 has been used in trials studying Autistic Disorder.
Investigational
Experimental
Experimental
Illicit
Displaying drugs 1301 - 1325 of 1455 in total